If you or a loved one have taken Zantac or generic ranitidine, you may have been exposed to a probable human carcinogen.
Zantac and generic forms of ranitidine have been sold for many years over-the-counter and by prescription to Canadians to treat heartburn, acid reflux, and other gastrointestinal conditions.
During digestion, as well as spontaneously as it sits on your shelf, ranitidine can break down into what Health Canada classifies as a probable human carcinogen: N-nitrosodimethylamine (NDMA).
If you have ingested Zantac or ranitidine, you may have been exposed to NDMA levels many thousands of times greater than what Health Canada and the Food and Drug Administration considers an acceptable daily limit.
Health Canada has requested a stop to further distribution of ranitidine products, and many of the pharmaceutical companies manufacturing it have already announced recalls.
Ranitidine products have been marketed in Canada for several decades without any warning of a potential to cause cancer.
Preszler Law is currently conducting a mass tort campaign for people who believe they developed cancer as a result of taking Zantac or generic ranitidine.
If a loved one died of cancer after taking Zantac or generic ranitidine, then the immediate family members may be entitled to compensation for wrongful death.
For more information on the FDA’s recall of Zantac and generic ranitidine, please visit here; or visit here for a list of Canadian products affected.
For pictures of the various ranitidine product boxes in order to know which product you or a loved one took, please visit here. Please ensure that all medication boxes, labels, and receipts related to the medication are kept in a safe place if they are still available to you.
If you or someone you know has suffered from any form of cancer after taking Zantac or generic ranitidine, please contact Preszler Law for a free consultation.
Call or text (416) 364-2000 or complete a Free Case Evaluation form
